Format

Send to

Choose Destination
Rejuvenation Res. 2018 Feb;21(1):61-66. doi: 10.1089/rej.2018.2056.

ATP Synthase, a Target for Dementia and Aging?

Author information

1
1 Panorama Research Institute , Sunnyvale, California.
2
2 Regenerative Sciences Institute , Sunnyvale, California.

Abstract

Advancing age is the biggest risk factor for development for the major life-threatening diseases in industrialized nations accounting for >90% of deaths. Alzheimer's dementia (AD) is among the most devastating. Currently approved therapies fail to slow progression of the disease, providing only modest improvements in memory. Recently reported work describes mechanistic studies of J147, a promising therapeutic molecule previously shown to rescue the severe cognitive deficits exhibited by aged, transgenic AD mice. Apparently, J147 targets the mitochondrial alpha-F1-ATP synthase (ATP5A). Modest inhibition of the ATP synthase modulates intracellular calcium to activate AMP-activated protein kinase to inhibit mammalian target of rapamycin, a known mechanism of lifespan extension from worms to mammals.

KEYWORDS:

aging; antioxidants; longevity; mitochondria; neurodegeneration

PMID:
29461942
DOI:
10.1089/rej.2018.2056
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center